Food Allergy Diagnostics & Therapeutics Market

The global food allergy diagnostics & therapeutics market size is projected to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing prevalence of food allergy.

The immune system of persons with food allergies reacts to particular proteins in food as if they were dangerous pathogens like bacteria, parasites, or viruses. Even a small amount of the allergy-causing food might cause symptoms such as bloating, hives, and enlarged airways. A food allergy can cause severe symptoms or even a life-threatening reaction called anaphylaxis in certain people. Food allergies affect 6 to 8% of children under the age of 3 and up to 3% of adults. While there is no cure for food allergies, some children outgrow them as they grow older. people often get confused between food allergy and food intolerance, which is a considerably more common reaction. Food intolerance is a less serious ailment that does not involve the immune system, despite how unpleasant it can be. The immune system of persons with food allergies wrongly recognizes a certain food or food ingredient as hazardous. In response, your immune system instructs cells to produce immunoglobulin E (IgE), an antibody that neutralizes the allergen-causing food or chemical. When a person eats even a small amount of the food, IgE antibodies detect it and tell your immune system to release histamine and other chemicals into the bloodstream. Allergy symptoms are caused by these substances.

Food allergies have traditionally been treated by avoiding the food that triggers the reaction. When symptoms of an allergy appear, people can also treat them. Oral immunotherapy is a new and investigative treatment for food allergies. It includes gradually increasing the amount of an allergen given to the person in order to raise the threshold at which a reaction occurs. Although oral immunotherapy is not available for all foods, the Food and Drug Administration (FDA) has approved Palforzia, a treatment for peanut allergy. Eggs, milk, and peanuts are the most prevalent food allergies among children. The signs and symptoms might be mild to severe. Food allergies have no traditional treatment, but oral immunotherapy gives hope, and patients can manage symptoms as they emerge. People can avoid allergic responses by avoiding food that contain the allergen.

Market Trends, Drivers, Restraints, and Opportunities

• Increasing prevalence of food allergies such as eggs, milk, wheat, fish, and tree nuts are projected to boost the market growth during the forecast period.
• Increasing awareness among people about food allergies is anticipated to drive the market growth during the forecast period.
• Growing demand for cost effective treatment of food allergies is expected to fuel the market growth in the coming years.
• Technological advancements and presence of novel products in the market are expected to drive the market growth in the coming year.
• High costs of a few drugs such as EpiPen is projected to hamper the market growth.
• Increased emphasis of R&D for new product development with higher efficacy is projected to offer lucrative opportunities for the market players.

Scope of the Report

The report on the global food allergy diagnostics & therapeutics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Market Segment Insights

Therapeutics segment is expected to account for a key share of the market
Based on product type, the food allergy diagnostics & therapeutics market is bifurcated into diagnostic products, therapeutic treatment type. The diagnostic products segment is further sub segmented into instruments, consumables, services, and tests type. The therapeutic treatment type segment is further sub segmented into antihistamines and epinephrine auto-injector. The test type segment is sub segmented into in vivo/skin and in vitro. Further the vivo/skin is sub segmented into skin prick test and patch test. The therapeutics segment is expected to account for a key share of the market during the forecast period owing/due to increased awareness about various treatment methods for the management of food allergies.

On the other hand, the diagnostic products segment is anticipated to expand at a rapid pace during the forecast period owing to the availability of numerous advanced and speedy test kits. In vitro testing has seen rapid growth due to increased demand for blood tests. Skin prick tests are also commonly used to diagnose food allergies, which is increasing the market acceptance of in vivo testing.

Peanut segment is expected to constitute a key share of the market
Based on allergen source, the food allergy diagnostics & therapeutics market is segmented into eggs, milk, peanuts, fish, shellfish, tree nuts, wheat, soy, and others. The peanut segment is expected to constitute a key share of the market during the forecast period owing to increasing prevalence of allergies from peanut. Food allergies in adults are caused by common allergens such as shellfish, peanuts, tree nuts, and fish, but food allergies in children are caused by peanuts, tree nuts, eggs, milk, wheat, or soy. Milk, soy, wheat, eggs, tree nuts, fish, shellfish, and peanuts account for over 90% of all allergies.

Hospitals & clinics segment is expected to represent a key share of the market
Based on end use, the food allergy diagnostics & therapeutics market is segmented into academic research institutes, hospitals & clinics, and diagnostics laboratories. The hospitals & clinics segment is expected to represent a key share of the market during the forecast period owing to increasing number of people taking treatment for allergies. The segment is also being driven by an increase in the number of allergy cases requiring hospitalization. Furthermore, since the danger of severe allergic reactions has increased, the number of early therapeutic interventions in hospitals and clinics has increased. The segment is also being driven by an increase in the number of allergy cases requiring hospitalization. Furthermore, since the danger of severe allergic reactions has increased, the number of early therapeutic interventions in hospitals and clinics has increased.

On the other hand, the diagnostic laboratories segment is anticipated to expand at a rapid pace during the forecast period owing/due to increasing adoption of allergy diagnostic kits in disease diagnosis. For food allergy diagnosis, allergists frequently recommend a blood or skin test to determine the presence of food-specific immunoglobulin E antibodies in the body. Furthermore, the growing number of diagnostic centers aids the growth of the diagnostic laboratories market.

Europe is anticipated to dominate the market
On the basis of regions, the food allergy diagnostics & therapeutics market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Europe is anticipated to dominate the market at an impressive CAGR during the forecast period. The regional market growth can be attributed to increasing prevalence of food allergies. In this region, fourteen allergens were discovered to be the most common causes of food allergies and intolerance. The market in this region is also being driven by rising awareness of the many therapies available for food allergies.

On the other hand, Asia Pacific is expected to exhibit a rapid growth rate in the coming years owing/due to increasing prevalence of food allergies such as peanut allergy. This is attributable to a variety of factors, including modernisation and lifestyle changes. Furthermore, the regional market is being pushed by the region's expanding population.

Segments

• Diagnostic Products
  • Instruments
  • Consumables
  • Services
  • Tests Type
    • In Vivo/Skin
      • Skin Prick Test
      • Patch Test
    • In Vitro
• Therapeutic Treatment Type
  • Antihistamines
  • Epinephrine auto-injector

• Eggs
• Milk
• Peanuts
• Fish
• Shellfish
• Tree Nuts
• Wheat
• Soy
• Others

• Academic Research Institutes
• Hospitals & Clinics
• Diagnostics Laboratories

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

• Allergy Therapeutics
• Cambridge Allergy Ltd
• Astellas Pharma, Inc.
• Immunomic Therapeutics, Inc.
• Prota Therapeutics Pty Ltd
• Aimmune Therapeutics
• Meridian Medical Technologies
• ALK-Abelló Ltd
• Medeca Pharma AB
• bioMérieux SA
• Omega Diagnostics Group PLC
• HYCOR Biomedical
• HOB Biotech Group Corp., Ltd.

Competitive Landscape

Key players competing in the food allergy diagnostics & therapeutics market are Allergy Therapeutics; Cambridge Allergy Ltd; Astellas Pharma, Inc.; Immunomic Therapeutics, Inc.; Prota Therapeutics Pty Ltd; Aimmune Therapeutics; Meridian Medical Technologies; ALK-Abelló Ltd; Medeca Pharma AB; bioMérieux SA; Omega Diagnostics Group PLC; HYCOR Biomedical; and HOB Biotech Group Corp., Ltd.

Some of key business strategies adopted by the companies are mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase/enhance their market shares.